These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 21780650

  • 1. [Methotrexate-induced changes in the concentration of antibodies to mutaded citrullinated vimentin in blood serum of patients with rheumatoid arthritis].
    Shilkina NP, Voronina MS, Vinogradov AA, Borisova OL.
    Ter Arkh; 2011; 83(5):10-3. PubMed ID: 21780650
    [Abstract] [Full Text] [Related]

  • 2. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S, Lundberg K, Engström A, Venables PJ, Toes RE, Holmdahl R, Klareskog L, Malmström V.
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [Abstract] [Full Text] [Related]

  • 4. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis.
    Koivula MK, Heliövaara M, Rissanen H, Palosuo T, Knekt P, Immonen H, Risteli J.
    Ann Rheum Dis; 2012 Oct; 71(10):1666-70. PubMed ID: 22419777
    [Abstract] [Full Text] [Related]

  • 5. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
    Bang H, Egerer K, Gauliard A, Lüthke K, Rudolph PE, Fredenhagen G, Berg W, Feist E, Burmester GR.
    Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutated citrullinated vimentin antibodies in rheumatoid arthritis.
    Kuna AT.
    Clin Chim Acta; 2012 Jan 18; 413(1-2):66-73. PubMed ID: 22037509
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X, Jia R, Zhao J, Li Z.
    J Rheumatol; 2009 Jun 18; 36(6):1136-42. PubMed ID: 19447936
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
    Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M.
    Arthritis Res Ther; 2006 Jun 18; 8(4):R119. PubMed ID: 16859519
    [Abstract] [Full Text] [Related]

  • 12. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
    Lequerré T, Jouen F, Brazier M, Clayssens S, Klemmer N, Ménard JF, Mejjad O, Daragon A, Tron F, Le Loët X, Vittecoq O.
    Rheumatology (Oxford); 2007 Mar 18; 46(3):446-53. PubMed ID: 16899502
    [Abstract] [Full Text] [Related]

  • 13. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
    Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR.
    J Rheumatol; 2008 Jun 18; 35(6):1002-8. PubMed ID: 18398946
    [Abstract] [Full Text] [Related]

  • 14. Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide.
    El-Barbary AM, Kassem EM, El-Sergany MA, Essa SA, Eltomey MA.
    J Rheumatol; 2011 May 18; 38(5):828-34. PubMed ID: 21362765
    [Abstract] [Full Text] [Related]

  • 15. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
    Feitsma AL, van der Voort EI, Franken KL, el Bannoudi H, Elferink BG, Drijfhout JW, Huizinga TW, de Vries RR, Toes RE, Ioan-Facsinay A.
    Arthritis Rheum; 2010 Jan 18; 62(1):117-25. PubMed ID: 20039411
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.
    Al-Jarallah K, Shehab D, Al-Attiyah R, Al-Azmi W, Al-Fadli A, Zafar Haider M, Panaccione R, Ghosh S.
    Inflamm Bowel Dis; 2012 Sep 18; 18(9):1655-62. PubMed ID: 22114016
    [Abstract] [Full Text] [Related]

  • 17. Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis.
    Turesson C, Mathsson L, Jacobsson LT, Sturfelt G, Rönnelid J.
    Ann Rheum Dis; 2013 Dec 18; 72(12):2047-8. PubMed ID: 23740235
    [No Abstract] [Full Text] [Related]

  • 18. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F.
    Ann Rheum Dis; 2005 Feb 18; 64(2):299-302. PubMed ID: 15166003
    [Abstract] [Full Text] [Related]

  • 19. Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis.
    Lindenberg L, Spengler L, Bang H, Dorner T, Maslyanskiy AL, Lapin SV, Ilivanova EI, Martinez-Gamboa L, Bastian H, Wittenborn E, Egerer K, Burmester GR, Feist E.
    Arthritis Res Ther; 2015 Aug 13; 17(1):206. PubMed ID: 26268352
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis.
    Damjanovska L, Thabet MM, Levarth EW, Stoeken-Rijsbergen G, van der Voort EI, Toes RE, Huizinga TW, van der Helm-van Mil AH.
    Ann Rheum Dis; 2010 Apr 13; 69(4):730-2. PubMed ID: 19451136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.